<DOC>
	<DOCNO>NCT00615459</DOCNO>
	<brief_summary>The study compare 24-hour spirometry profile indacaterol placebo tiotropium active control patient chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>A Crossover Study Determine Effect Lung Function Indacaterol Patients With Moderate Severe Chronic Obstructive Pulmonary Disease ( COPD ) , Using Tiotropium Active Control</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male female adult age ≥ 40 year , sign Informed Consent Form prior initiation studyrelated procedure Cooperative patient diagnosis chronic obstructive pulmonary disease ( COPD ) ( moderate severe classify Global initiative chronic obstructive lung disease ( GOLD ) Guidelines , 2006 ) : 1 . Smoking history least 10 pack year ( current previous smoker ) 2 . Postbronchodilator force expiratory volume 1 second ( FEV1 ) &lt; 80 % ≥30 % predict normal value . 3 . Postbronchodilator FEV1/Forced vital capacity ( FVC ) &lt; 70 % Patients hospitalize COPD exacerbation 6 week prior Visit 1 runin period Patients require longterm oxygen therapy chronic hypoxemia Patients respiratory tract infection within 6 week prior Visit Patients concomitant pulmonary disease Patients history asthma Patients diabetes Type I uncontrolled diabetes Type II Any patient lung cancer history lung cancer Any patient active cancer history cancer le 5 year disease free survival time Patients history long QT syndrome whose QTc interval ( Bazett 's ) measure Visit 1 randomization prolong Patients vaccinated live attenuate vaccine within 30 day prior screen runin period . Patients unable successfully use dry powder inhaler device , MDI perform spirometry measurement Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Chronic obstructive pulmonary disease , indacaterol , tiotropium , placebo control</keyword>
</DOC>